Find an expert

Dr Jon Fanning is a dedicated clinician with 15 years’ experience in clinical medicine including specialist training in Anaesthesia, Intensive care, and Neurology. Passionate about advancing clinical research and advocating for clinician-researchers, Jon balances research leadership, teaching and mentoring alongside his own research and active medical practice. Jon’s career includes a diverse research portfolio with a strong focus on harm minimisation (especially neurological injury) in operative and critical care settings. He has undertaken dedicated training in clinical trials (University of Oxford Clinical Trials Unit, UK), and in epidemiology (Harvard University, USA). In 2022 Jon undertook a Visiting Fulbright Scholarship in Cardiac intensive care and ECMO (Cardiovascular Surgical Intensive Care Unit, Johns Hopkins Medicine, USA).

To facilitate innovative discovery and advances in the fields of perioperative medicine, clinical trials, and ECMO, Jon invests considerable effort in building research capacity through collaboration with national and international research institutions. Valuing the diverse perspectives of multidisciplinary colleagues at all stages of their career, Jon recruits and supervises senior scientists, clinician-researchers and top PhD and MPhil students and looks to repay the generosity he has received from supervisors and mentors.

Additionally, Jon fosters research networks and ensures research integrity through leadership positions such as current positions as co-chair of the Queensland Cardiovascular Research Network; and as Expert Panel Member and writing committee representative for Therapeutic Guidelines.

Wendy Goodwin is a clinical veterinary anaesthetist and academic at the School of Veterinary Science, University of Queensland since 2010. She received her veterinary degree and Doctor of Philosophy from the University of Queensland, with her doctoral research focused on 'Studies of Alfaxalone in Horses'. Wendy is a registered specialist veterinary anaesthetist and Fellow of the Australian & New Zealand College of Veterinary Scientists in Veterinary Anaesthesia and Critical Care, and additionally holds Membership in Equine Medicine.

Wendy is internationally recognized for her expertise with the anaesthetic molecule alfaxalone in various formulations across multiple species. Her doctoral research established foundational knowledge on alfaxalone use in horses, and she has continued to advance the understanding of this important anaesthetic agent through her ongoing research. This expertise encompasses both traditional and novel alfaxalone formulations, dosing strategies, and applications across species ranging from companion animals to large animals and laboratory species.

Beyond her alfaxalone expertise, Wendy is passionate about veterinary anaesthesia and analgesia, having dedicated the majority of her professional career to pursuing excellence in this field. Her clinical anaesthetic experience has covered a wide range of species including horses, small animal companion animals, farm animals, avian and exotic animals and animals used in scientific research. Her research portfolio spans veterinary anaesthetic safety culture, innovative pain management and total intravenous anaesthesia techniques, critical care, traumatic haemorrhage and injury, and translational large animal models for medical research.

Beyond traditional anaesthetic research, Wendy examines leadership and workplace culture in veterinary practice, investigating how leadership styles impact error disclosure and safety climate. She continues to publish in peer-reviewed journals and present at international conferences, demonstrating her ongoing commitment to advancing veterinary anaesthesia and improving both clinical outcomes and professional wellbeing.

MBChB FRCA FANZCA FFICM PhD

Prof Lipman is Executive Director of the Burns Trauma & Critical Care Research Centre; Professor of Anesthesiology & Critical Care, The University of Queensland and until recently (for 23 years) was Director of Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital; He holds Honorary Professorial appointments at Chinese University of Hong Kong, Unversity of Witwatersrand (South Africa) and Qeensland University of Technology.

He has qualifications in anesthesia and intensive care and has set up and been in charge of a number of Intensive Care and Trauma Units in South Africa before coming to Australia in 1997. he currently manages a large multidisciplinary research team with an output of over 120 peer-reviewed articles per annum. He has supervised dozens of PhD students to completion and is currently supervising 6 PhD, 1 MPhil and 1 MBBS/Hons students. Prof Lipman has been instrumental in developing the anaesthesiology and critical care component of a graduate medical program for Queensland and continues to lecture to medical and postgraduate students.

Prof Lipman is the author of over 550 peer reviewed publications, 30 book chapters and has been invited to deliver over 120 lectures at national and international conferences in many countries across the world. His research interests include all aspects of infection management in intensive care and he has a special interest in the pharmacokinetics of antibiotic dosage, an area in which he received his MD in 2006. His research into antibiotic usage in acute situations has received international recognition and he is regarded as an expert in the field. As such, he and his research team have conducted and presently conduct a number of clinical trials in Australia, New Zealand, Hong Kong, Europe and the UK.

Prof Lipman is an Editorial Board member for 10 International Journals, is Section Editor on four Antibiotic related Journals, reviews for 23 journals and is an external reviewer for NHMRC project grants (Local) as well as equivalent for a number overseas countries.

He is Chief Investigator on a 7000 patient International Randomised Controlled Trial comparing bolus dosing versus continuous infusions of meropenem and piperacillin-tazobactam